NASDAQ:ANGO
AngioDynamics Stock News
$5.87
+0.170 (+2.98%)
At Close: Mar 28, 2024
AngioDynamics (ANGO) Q4 Earnings Match Estimates, Revenues Top
10:51am, Wednesday, 14'th Jul 2021
AngioDynamics (ANGO) registers strong revenue growth across all its GBUs in fiscal 2021 Q4.
AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q4 2021 Results - Earnings Call Transcript
12:53pm, Tuesday, 13'th Jul 2021
AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q4 2021 Results - Earnings Call Transcript
AngioDynamics Breaks-Even In FY21, Issues Mixed Forecasts For FY22
07:53am, Tuesday, 13'th Jul 2021
AngioDynamics Inc (NASDAQ: ANGO) reports break-even in 4Q of 2021 with adjusted EPS of $0.00, a turnaround from EPS of (0.06) posted a year ago. The Company witnessed the pressure from COVID-19 gra
AngioDynamics Announces Details for Investor & Technology Day on July 13, 2021
06:30pm, Thursday, 08'th Jul 2021
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology,
AngioDynamics to Report Fiscal 2021 Fourth Quarter and Full-Year Financial Results and Host Investor & Technology Day on July 13, 2021
04:01pm, Thursday, 24'th Jun 2021
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology,
AngioDynamics (ANGO) Hits New 52-Week High: What's Driving It?
12:02pm, Tuesday, 22'nd Jun 2021
AngioDynamics (ANGO) is optimistic about maintaining its robust product portfolio.
AngioDynamics (ANGO) Receives FDA Nod for AlphaVac System
10:31am, Wednesday, 09'th Jun 2021
AngioDynamics (ANGO) gets 510(k) clearance from the FDA for the AlphaVac System for the non-surgical removal of thrombi or emboli from the vasculature.
AngioDynamics (ANGO) Up 4.3% Since Last Earnings Report: Can It Continue?
12:02pm, Thursday, 29'th Apr 2021
AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock?
AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System
06:00am, Monday, 12'th Apr 2021
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology t
AngioDynamics to Present at the Needham Virtual Healthcare Conference
04:01pm, Monday, 05'th Apr 2021
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, t
AngioDynamics (ANGO) Q3 Earnings and Revenues Top Estimates
01:38pm, Wednesday, 31'st Mar 2021
AngioDynamics (ANGO) witnesses revenue growth across two business segments in fiscal Q3.
AngioDynamics (ANGO) Soars 7.9%: Is Further Upside Left in the Stock?
05:18am, Wednesday, 31'st Mar 2021
AngioDynamics (ANGO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down t
AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q3 2021 Results - Earnings Call Transcript
12:58pm, Tuesday, 30'th Mar 2021
AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q3 2021 Results - Earnings Call Transcript
AngioDynamics (ANGO) Surpasses Q3 Earnings and Revenue Estimates
09:06am, Tuesday, 30'th Mar 2021
AngioDynamics (ANGO) delivered earnings and revenue surprises of 166.67% and 4.04%, respectively, for the quarter ended February 2021. Do the numbers hold clues to what lies ahead for the stock?
ANGO Stock Price Increased Over 10% Pre-Market: Why It Happened
08:37am, Tuesday, 30'th Mar 2021
The stock price of AngioDynamics, Inc. (NASDAQ: ANGO) increased by over 10% pre-market. This is why it happened.